Work

Pharmacogenomic analysis from a phase III study of pemetrexed plus carboplatin (PC) versus etoposide plus carboplatin (EC) in chemonaive patients (pts) with extensive-stage disease small cell lung cancer (ED-SCLC)

Year: 2009

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2009.27.15_suppl.8030

Authors: E. F. Smit, M. A. Socinski, B. P. Mullaney, S. P. Myrand, E. Powell, P. Lorigan, C. Kaiser, S. C. Guba, N. Thatcher

Institutions: University of North Carolina at Chapel Hill, The Christie NHS Foundation Trust

Language: English

Topic: Pharmacogenetics and Drug Metabolism

Subfield: Pharmacology

Field: Pharmacology, Toxicology and Pharmaceutics

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2229855073

Cites:

Cited by: 13

Related to: 10